Adrián Llerena-Ruiz
AuthID: R-000-HSC
1
TITLE: Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans
AUTHORS: Rodrigues Soares, F; Peñas Lledó, EM; Tarazona Santos, E; Sosa Macías, M; Terán, E; López López, M; Rodeiro, I; Moya, GE; Calzadilla, LR; Ramírez Roa, R; Grazina, M; Estévez Carrizo, FE; Barrantes, R; LLerena, A; Tinoco, CA; Álvárez, M; Borbón, A; Céspedes Garro, C; Cobaleda, J; de Andrés, F; ...More
PUBLISHED: 2020, SOURCE: CLINICAL PHARMACOLOGY & THERAPEUTICS, VOLUME: 107, ISSUE: 1
AUTHORS: Rodrigues Soares, F; Peñas Lledó, EM; Tarazona Santos, E; Sosa Macías, M; Terán, E; López López, M; Rodeiro, I; Moya, GE; Calzadilla, LR; Ramírez Roa, R; Grazina, M; Estévez Carrizo, FE; Barrantes, R; LLerena, A; Tinoco, CA; Álvárez, M; Borbón, A; Céspedes Garro, C; Cobaleda, J; de Andrés, F; ...More
PUBLISHED: 2020, SOURCE: CLINICAL PHARMACOLOGY & THERAPEUTICS, VOLUME: 107, ISSUE: 1
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting Full Text
AUTHORS: Eva Penas LLedo; Enrique Teran; Marta Sosa Macias; Carlos Galaviz Hernandez; Jose Pedro Gil; Sujit Nair; Shyam Diwakar; Isabel Hernandez; Julio Lara Riegos; Ronald Ramirez Roa; Ignacio Verde; Eduardo Tarazona Santos; Juan Molina Guarneros; Graciela Moya; Lembit Raego; Adrian LLerena;
PUBLISHED: 2020, SOURCE: CLINICAL THERAPEUTICS, VOLUME: 42, ISSUE: 8
AUTHORS: Eva Penas LLedo; Enrique Teran; Marta Sosa Macias; Carlos Galaviz Hernandez; Jose Pedro Gil; Sujit Nair; Shyam Diwakar; Isabel Hernandez; Julio Lara Riegos; Ronald Ramirez Roa; Ignacio Verde; Eduardo Tarazona Santos; Juan Molina Guarneros; Graciela Moya; Lembit Raego; Adrian LLerena;
PUBLISHED: 2020, SOURCE: CLINICAL THERAPEUTICS, VOLUME: 42, ISSUE: 8
INDEXED IN: WOS
WOS3
TITLE: Pharmacogenetics and Therapeutic Drug Monitoring of Fluoxetine in a Real-World Setting: A PK/PD Analysis of the Influence of (Non-)Genetic Factors
AUTHORS: Paulo Magalhaes; Gilberto Alves; Ana Fortuna; Adrian Llerena; Amilcar Falcao;
PUBLISHED: 2020, SOURCE: EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, VOLUME: 28, ISSUE: 5
AUTHORS: Paulo Magalhaes; Gilberto Alves; Ana Fortuna; Adrian Llerena; Amilcar Falcao;
PUBLISHED: 2020, SOURCE: EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, VOLUME: 28, ISSUE: 5
INDEXED IN: WOS
WOS4
TITLE: Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms Full Text
AUTHORS: Dorado, P; Lopez Torres, E; Em Penas LLedo; Martinez Anton, J; LLerena, A;
PUBLISHED: 2013, SOURCE: PHARMACOGENOMICS JOURNAL, VOLUME: 13, ISSUE: 4
AUTHORS: Dorado, P; Lopez Torres, E; Em Penas LLedo; Martinez Anton, J; LLerena, A;
PUBLISHED: 2013, SOURCE: PHARMACOGENOMICS JOURNAL, VOLUME: 13, ISSUE: 4
5
TITLE: An action-research programme with secondary education teachers on teaching and learning photosynthesis
AUTHORS: Paula Domingos Grilo; Carlos Reis Grilo; Constantino Ruiz; Vicente Mellado;
PUBLISHED: 2012, SOURCE: JOURNAL OF BIOLOGICAL EDUCATION, VOLUME: 46, ISSUE: 2
AUTHORS: Paula Domingos Grilo; Carlos Reis Grilo; Constantino Ruiz; Vicente Mellado;
PUBLISHED: 2012, SOURCE: JOURNAL OF BIOLOGICAL EDUCATION, VOLUME: 46, ISSUE: 2
INDEXED IN: Scopus WOS
Scopus WOS6
TITLE: CYP2D6 and the severity of suicide attempts
AUTHORS: Eva M Penas Lledo; Hilario Blasco Fontecilla; Pedro Dorado; Concepcion Vaquero Lorenzo; Enrique Baca Garcia; Adrian Llerena;
PUBLISHED: 2012, SOURCE: PHARMACOGENOMICS, VOLUME: 13, ISSUE: 2
AUTHORS: Eva M Penas Lledo; Hilario Blasco Fontecilla; Pedro Dorado; Concepcion Vaquero Lorenzo; Enrique Baca Garcia; Adrian Llerena;
PUBLISHED: 2012, SOURCE: PHARMACOGENOMICS, VOLUME: 13, ISSUE: 2
INDEXED IN: Scopus WOS
Scopus WOS7
TITLE: Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions
AUTHORS: Adrian LLerena; Pedro Dorado; Eva M Penas LLedo;
PUBLISHED: 2011, SOURCE: PHARMACOGENOMICS, VOLUME: 12, ISSUE: 3
AUTHORS: Adrian LLerena; Pedro Dorado; Eva M Penas LLedo;
PUBLISHED: 2011, SOURCE: PHARMACOGENOMICS, VOLUME: 12, ISSUE: 3
INDEXED IN: WOS
WOS8
TITLE: Relevance of CYP2D6-1584C > G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients
AUTHORS: Pedro Dorado; Eva M Penas Lledo; Alfredo de la Rubia; Adrian Llerena;
PUBLISHED: 2009, SOURCE: PHARMACOGENOMICS, VOLUME: 10, ISSUE: 7
AUTHORS: Pedro Dorado; Eva M Penas Lledo; Alfredo de la Rubia; Adrian Llerena;
PUBLISHED: 2009, SOURCE: PHARMACOGENOMICS, VOLUME: 10, ISSUE: 7
9
TITLE: Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers
AUTHORS: Eva M Penas Lledo; Pedro Dorado; Rodrigo Pacheco; Idilio Gonzalez; Adrian Llerena;
PUBLISHED: 2009, SOURCE: PHARMACOGENOMICS, VOLUME: 10, ISSUE: 7
AUTHORS: Eva M Penas Lledo; Pedro Dorado; Rodrigo Pacheco; Idilio Gonzalez; Adrian Llerena;
PUBLISHED: 2009, SOURCE: PHARMACOGENOMICS, VOLUME: 10, ISSUE: 7
INDEXED IN: Scopus WOS
Scopus WOS10
TITLE: Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms
AUTHORS: Enrique Lopez Torres; Jesus Salomon; Francis Vicario; Eva Penas LLedo; Pedro Dorado; Adrian Llerena;
PUBLISHED: 2008, SOURCE: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, VOLUME: 28, ISSUE: 3
AUTHORS: Enrique Lopez Torres; Jesus Salomon; Francis Vicario; Eva Penas LLedo; Pedro Dorado; Adrian Llerena;
PUBLISHED: 2008, SOURCE: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, VOLUME: 28, ISSUE: 3
INDEXED IN: Scopus WOS
Scopus WOS